Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Endocrinology, Diabetes & Metabolism Case Reports|December 12, 2018
Autoimmune hypoglycaemia caused by alpha-lipoic acid: a rare condition in Caucasian patientsA Veltroni, G Zambon, S Cingarlini, et al.
Targeted Oncology|August 15, 2012
Profiling mTOR pathway in neuroendocrine tumorsS Cingarlini, M Bonomi, V Corbo, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 5, 2020
Is Laparoscopic CME Right Hemicolectomy an Optimal Indication for NET of the Right Colon and Terminal Ileum?C Pedrazzani, C Conti, A Valdegamberi, et al.
Pathologica|February 15, 2017
Pathological complete response in a patient affected by multiple synchronous, breast and lung primary malignancies: a case report and review of the literatureA Nottegar, C Luchini, S Cingarlini, et al.
Endocrine|May 26, 2021
Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndromeF Penitenti, L Landoni, M Scardoni, et al.
Journal of Chemotherapy (Florence, Italy)|August 2, 2011
Carboplatin and gemcitabine in first-line treatment of elderly patients with advanced non-small cell lung cancer: data from a retrospective studyG Genestreti, N Giovannini, M Frizziero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
Simplified gemcitabine and platin regimen in patients with advanced or metastatic non-small cell lung cancer (NSCLC) to be proposed as neoadjuvant therapyG Cartei, S Binato, C Sacco, et al.
Pathologica|August 17, 2013
Lung metastasis from TTF-1 positive sigmoid adenocarcinoma. pitfalls and managementA Remo, C Zanella, M Pancione, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2013
A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancerB Frigerio, G Fracasso, E Luison, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literatureD Pastorelli, G Cartei, F Zustovich, et al.
Pageof 2